The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001480 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2017-07-02
Summary
The purpose of this study is to evaluate people with mild memory problems, those with dementia, those at risk for developing Alzheimer's disease (AD), and healthy volunteers to identify markers of AD before the changes that occur with the disease begin.
The origin and markers of progression for Alzheimer's disease (AD) are relatively obscure. Despite increased understanding of the underlying biology of AD, its clinical diagnosis is still made only after progressive cognitive decline; definitive diagnosis is confirmed at autopsy. This study will examine biomarker changes over time in a distinct cohort of people with an increased risk of developing AD. The study will also identify and track biological changes that occur with progressive dementia and compare those changes to the known cognitive and emotional disturbances that characterize AD.
Individuals with a first-degree relative with AD will be recruited into an at-risk cohort. They will be followed and compared to a group of healthy volunteers for a minimum of 8 years.
Conditions
- Alzheimer's Disease
- Dementia
- Healthy
- Memory Disorder
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1995-03-21
- Completion
- 2007-03-31
Countries
- United States
Study Locations
More Related Trials
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
NCT02854917 ·Status: COMPLETED
-
Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
NCT00004557 ·Status: COMPLETED
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
NCT00097916 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
NCT00255086 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
NCT00305903 ·Status: COMPLETED ·Phase: PHASE4
-
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
NCT00855868 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
NCT02553928 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
NCT00857649 ·Status: TERMINATED ·Phase: PHASE3
-
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
NCT00505167 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
NCT00322153 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects
NCT00605046 ·Status: TERMINATED ·Phase: PHASE1
-
Memory and Mental Health in Aging
NCT02988908 ·Status: COMPLETED ·Phase: PHASE4
-
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
NCT03089827 ·Status: ENROLLING_BY_INVITATION
-
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
NCT04994847 ·Status: ENROLLING_BY_INVITATION
-
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410 ·Status: RECRUITING
-
Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
NCT01841905 ·Status: UNKNOWN
-
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
NCT01028053 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
NCT00257673 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
NCT00874939 ·Status: TERMINATED ·Phase: PHASE1
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.
NCT04522960 ·Status: UNKNOWN ·Phase: NA